Altering chromatic aberration: how this latest trend in intraocular-lens design affects visual quality in pseudophakic patients.

Journal Information

Full Title: Eye Vis (Lond)

Abbreviation: Eye Vis (Lond)

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Ophthalmology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThe study procedures adhered to the tenets of the Declaration of Helsinki and were conducted in compliance with Ethical Committee's approval (S-392/2011) granted by Heidelberg Medical Faculty's review board. Informed consent was obtained from all participants. Consent for publicationNot applicable. Competing interestsG. U. Auffarth and R. Khoramnia report grants, personal fees, nonfinancial support and consulting fees from Johnson and Johnson Vision Care, Inc. and Alcon Laboratories, Inc., grants, personal fees, and nonfinancial support from Hoya Corp., Kowa Co. Ltd., Oculentis/Teleon, Carl Zeiss Meditec AG, Santen and SIFI, grants and personal fees from Bausch + Lomb, Biotech and OCULUS Optikgeräte GmbH, and grants from AcuFocus, Inc., Eyebright, Hanita, Ophtec, Ophthalmopro, Physiol, Rayner and VSY, outside the submitted work. G. Łabuz, H. Güngör and T. M. Yildirim declare no potential conflict of interest. The University of Heidelberg holds a pending patent application (no. EP22187235) entitled "Lens with extended depth of focus by inducing an excess of longitudinal chromatic aberration," with G.U. Auffarth and G. Łabuz as inventors. Competing interests G. U. Auffarth and R. Khoramnia report grants, personal fees, nonfinancial support and consulting fees from Johnson and Johnson Vision Care, Inc. and Alcon Laboratories, Inc., grants, personal fees, and nonfinancial support from Hoya Corp., Kowa Co. Ltd., Oculentis/Teleon, Carl Zeiss Meditec AG, Santen and SIFI, grants and personal fees from Bausch + Lomb, Biotech and OCULUS Optikgeräte GmbH, and grants from AcuFocus, Inc., Eyebright, Hanita, Ophtec, Ophthalmopro, Physiol, Rayner and VSY, outside the submitted work. G. Łabuz, H. Güngör and T. M. Yildirim declare no potential conflict of interest. The University of Heidelberg holds a pending patent application (no. EP22187235) entitled "Lens with extended depth of focus by inducing an excess of longitudinal chromatic aberration," with G.U. Auffarth and G. Łabuz as inventors."

Evidence found in paper:

"Funding Open Access funding enabled and organized by Projekt DEAL. The David J Apple Laboratory receives support from the Klaus Tschira Foundation, Heidelberg, Germany. The funding organizations had no role in the design or conduct of this research or in the preparation of the manuscript."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025